loadpatents
name:-0.027081966400146
name:-0.0088901519775391
name:-0.0077559947967529
TARDIF; Jean-Claude Patent Filings

TARDIF; Jean-Claude

Patent Applications and Registrations

Patent applications and USPTO patent grants for TARDIF; Jean-Claude.The latest application filed is for "early administration of low-dose colchicine after myocardial infarction".

Company Profile
8.8.27
  • TARDIF; Jean-Claude - Montreal CA
  • TARDIF; Jean-Claude - Laval CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Early Administration Of Low-dose Colchicine After Myocardial Infarction
App 20220249409 - TARDIF; Jean-Claude
2022-08-11
Early administration of low-dose colchicine after myocardial infarction
Grant 11,400,063 - Tardif August 2, 2
2022-08-02
Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent
Grant 11,401,554 - Dube , et al. August 2, 2
2022-08-02
Methods For Treating Or Preventing Cardiovascular Disorders And Lowering Risk Of Cardiovascular Events
App 20210290623 - DUBE; Marie-Pierre ;   et al.
2021-09-23
Methods For Delaying Occurrence Of New-onset Type 2 Diabetes And For Slowing Progression Of And Treating Type 2 Diabetes
App 20210236442 - DUBE; Marie-Pierre ;   et al.
2021-08-05
Early Administration Of Low-dose Colchicine After Myocardial Infarction
App 20210145773 - TARDIF; Jean-Claude
2021-05-20
Cetp Inhibitors For Therapeutic Use
App 20210017597 - Dube; Marie-PIerre ;   et al.
2021-01-21
Genetic Markers For Predicting Responsiveness To Therapy With Hdl-raising Or Hdl Mimicking Agent
App 20200239960 - Dube; Marie-Pierre ;   et al.
2020-07-30
Methods For Treating Or Preventing Cardiovascular Disorders And Lowering Risk Of Cardiovascular Events
App 20200222406 - DUBE; Marie-Pierre ;   et al.
2020-07-16
CETP inhibitors for therapeutic use
Grant 10,711,303 - Dube , et al.
2020-07-14
Genetic markers for predicting responsiveness to therapy with HDL-raising or HDL mimicking agent
Grant 10,584,385 - Dube , et al.
2020-03-10
A Co-culture System And Method For In Vitro Assessment Of Reverse Cholesterol Transport
App 20190284527 - RHAINDS; David ;   et al.
2019-09-19
Cetp Inhibitors For Therapeutic Use
App 20190226020 - Dube; Marie-Pierre ;   et al.
2019-07-25
Methods For Treating Or Preventing Cardiovascular Disorders And Lowering Risk Of Cardiovascular Events
App 20190070178 - DUBE; Marie-Pierre ;   et al.
2019-03-07
Cetp Inhibitors For Therapeutic Use
App 20180155784 - Dube; Marie-Pierre ;   et al.
2018-06-07
Dalcetrapib for therapeutic use
Grant 9,909,178 - Dube , et al. March 6, 2
2018-03-06
Genetic Markers For Predicting Responsiveness To Therapy With Hdl-raising Or Hdl Mimicking Agent
App 20170233812 - Dube; Marie-Pierre ;   et al.
2017-08-17
Genetic Markers For Predicting Responsiveness To Therapy
App 20160244826 - Dube; Marie-Pierre ;   et al.
2016-08-25
Genotyping Tests And Methods For Evaluating Plasma Creatine Kinase Levels
App 20160230231 - Dube; Marie-Pierre ;   et al.
2016-08-11
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction Comprising An Apolipoprotein Peptide/phospholipid Complex
App 20150374675 - TARDIF; Jean-Claude ;   et al.
2015-12-31
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction Comprising An Apolipoprotein Peptide/phospholipid Complex
App 20140309426 - TARDIF; Jean-Claude ;   et al.
2014-10-16
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction Comprising An Apolipoprotein Peptide/phospholipid Complex
App 20130197226 - Tardif; Jean-Claude ;   et al.
2013-08-01
Method for the treatment of valvular disease
Grant 8,163,699 - Tardif April 24, 2
2012-04-24
Pharmaceutical Compositions For The Treatment Of Left Ventricular Diastolic Dysfunction
App 20120021982 - Tardif; Jean-Claude ;   et al.
2012-01-26
Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
App 20110288072 - Benatar; Vidal ;   et al.
2011-11-24
Method for detecting a biomarker of oxidative stress in a biological sample
Grant 8,030,010 - Des Rosiers , et al. October 4, 2
2011-10-04
Method for quantifying oxidative stress caused by different biological pathways
Grant 7,993,859 - Des Rosiers , et al. August 9, 2
2011-08-09
Method And Compound For The Treatment Of Valvular Disease
App 20110092430 - Tardif; Jean-Claude
2011-04-21
Method For Quantifying Oxidative Stress Caused By Different Biological Pathways
App 20100330683 - Des Rosiers; Christine ;   et al.
2010-12-30
Method and Compound for the Treatment of Valvular Disease
App 20090186808 - Tardif; Jean-Claude
2009-07-23
Use of ivabradine for obtaining medicaments intended for the treatment of endothelial dysfunction
App 20080200450 - Benatar; Vidal ;   et al.
2008-08-21
Method and compounds to decrease the incidence of atrial fibrillation (AF) in patients with left ventricular dysfunction
App 20040255959 - Ducharme, Anique ;   et al.
2004-12-23
Methods of reversing and preventing cardiovascular pathologies
App 20030181520 - Glass, Mitchell ;   et al.
2003-09-25
Method for identification and visualization of atrial tissue and therapeutical use thereof
App 20030120142 - Dubuc, Marc ;   et al.
2003-06-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed